HealthStream (HSTM) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $0.23
- Estimate
- $0.18
- Surprise
- +27.8%
- Score at report (before → after)
- 5.5 → 5.7/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
HealthStream (HSTM) beat the $0.18 estimate with adjusted EPS of $0.23 — a large 27.8% upside surprise. TrendMatrix's engine moved from Hold (5.5/10) to Buy (Wait) at 5.7/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates HSTM Sell at 4.7/10.
3 of the last 4 quarters beat the estimate; this quarter's +27.8% surprise compares with a +19.4% four-quarter average. Next scheduled report: 2027-02-22.
What supports the rating
- Strong earnings beat streak (3/4)
What argues against it
- Concentration risk — Customer: healthcare industry
- Weak overall score: 4.7/10
- Weak growth
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $27.68
- Price target
- $30.60
- Stop
- $26.59
- Upside to target
- +10.5%
- Reward-to-risk
- 0.9:1
The stock trades at 40.5× trailing but 30.4× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 19 — a level conventionally read as oversold.
Model outputs from TrendMatrix’s engine as of 2026-11-17 — shown for context, not personalized investment advice.
HSTM at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Health Information Services
- Market cap
- $855.8M
- P/E (fwd)
- 30.4
- P/E (ttm)
- 40.5
- 52-week range
- $19.50–$35.61
- Off 52-week high
- 22.3%
- RSI (14)
- 19
- Volume vs avg
- 0.88×
- Score today
- 4.7/10